May 26 (Reuters) - Zomedica Pharmaceuticals Corp ZOM.V
* Zomedica pharmaceuticals corp announces first quarter 2016
financial results of Zomedica Pharmaceuticals Inc.
* Recorded net loss and comprehensive loss for three months
ended March 31, 2016 of $931,642 or $0.01 per share.
* Expects research and development expenditures throughout
2016 will be higher as activities accelerate.
Source text for Eikon: ID:nGNXMSSTBa
Further company coverage: ZOM.V
(Bengaluru Newsroom: +1-646-223-8780)